Genkyotex Reports Clinical Evidence of Anti-fibrotic Activity by GKT831 in Liver Fibrosis Patients

    NEXT STORY
    VALNEVA Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones
    PREV STORY
    Ziopharm Oncology to Host Conference Call to Discuss First Quarter 2019 Financial Results on May 8, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Leap Therapeutics Announces Collaboration With EORTC to Evaluate DKN-01 in Combination with PD-L1 Cancer Immunotherapy and Chemotherapy In Esophagogastric and Biliary Tract Cancers

    CAMBRIDGE, Mass., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

    author_avatar
    NASDAQ Market News

    Cynata Reports Positive 28-day Data From Cohort B of Phase 1 Trial of CYP-001 in GvHD

    MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine ...

    author_avatar
    NASDAQ Market News

    COVID-19 Vaccine– Pipeline Review, 2020: More than 160 Vaccines & Treatment Candidates Under R&D

    author_avatar
    NASDAQ Market News